ValueQ3, 24Q4, 24Q1, 25Q2, 25Q3, 25TTMCash from investing activities167 K00000Cash from financing activities-9.1 M35 M7.5 M-2.85 M1.37 M41.02 MFree cash flow-35.49 M12.36 M22.63 M31.42 M4.29 M70.69 M
Esperion Therapeutics Inc
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.